7 best EDC platforms for Latin America trials in 2026

A site in São Paulo needs its case report forms in Portuguese. A site in Bogotá needs them in Spanish, on a connection that drops mid-afternoon. Your procurement team wants one contract, not five. If your electronic data capture (EDC) platform treats every country as a separate build, a single protocol amendment turns into a queue of vendor tickets across your whole Latin America footprint. Viedoc's EDC software is built for exactly that kind of multi-country program, with study builds typically completed in 8 to 12 weeks and support for 40-plus languages across 75-plus countries. This comparison reviews seven EDC platforms against the criteria that actually matter for Latin America programs: language coverage at the site level, regulatory flexibility across multiple health authorities, build speed, and support that spans several time zones.

You're not choosing a platform for a single-country trial. You're weighing how much of the configuration work your own data management team can own versus how much routes back to a vendor every time a country adds a site or a regulator asks for a documentation change. That decision shapes your timeline and your margin for the life of the program, not just the first study.

Enterprise platforms built around a single dominant regulatory environment often assume a level of in-house programming support that a lean CRO or growth-stage sponsor running trials across Brazil, Mexico, Argentina, and Colombia simply doesn't have on staff. Medidata's build cycle can stretch toward 90 days for a single study; multiply that across several countries with their own eCRF variants and the delay compounds fast. The platforms below are reviewed on how well they hold up once a protocol crosses a border.

Best EDC solutions: quick comparison

These seven eClinical platforms represent the most evaluated options for CROs and sponsors running trials across Latin America, reviewed across language support, regulatory flexibility, build speed, and support coverage.

1. Viedoc

Viedoc's EDC software has run more than 8,000 studies across 75-plus countries, with study builds typically completed in 8 to 12 weeks, averaging 10. The no-code Designer means your data management team configures forms, edit checks, and workflows directly, rather than filing a ticket every time a site in a new country needs a form adjustment.

For a program spanning Brazil, Mexico, Argentina, and beyond, that self-service model matters more than raw feature count. Viedoc's ePRO software supports 40-plus languages, including Spanish and Portuguese, so participant-facing diaries and questionnaires reach sites in their working language rather than defaulting to English. Pricing is transparent and study-based, with unlimited user seats included, so adding sites in a new country doesn't add a per-seat cost.

Viedoc is ISO 27001 and SOC 2 certified, and supports 21 CFR Part 11, GDPR, HIPAA, and ICH GCP compliance, backed by 24/7 support across global offices. Every Viedoc-powered study that has faced FDA scrutiny to date has passed, and the Viedoc Inspection Readiness Packet (VIRP) gives every customer structured audit-readiness documentation without an extra line item.

"Viedoc is a very user-friendly interface, easy to understand and navigate through. It offers customisable study workflow and tailoring it according to trial specification is easy." Sanchita V. - Data Manager

• Build speed: study builds typically completed in 8 to 12 weeks, averaging 10
• Language support: available in 40-plus languages, including Spanish and Portuguese
• Study scale: 8,000-plus studies run across 75-plus countries
• Compliance: 21 CFR Part 11, GDPR, HIPAA, ICH GCP; ISO 27001 and SOC 2 certified
• Pricing: unlimited user seats, no per-user fees, transparent study-based licensing
• No-code Designer: studies configured in-house by certified data managers, no vendor-side programmer required

2. Medidata

Medidata offers Rave EDC, an electronic data capture system supporting data collection, management, cleaning, and reporting across Phase I through Phase IV trials. The platform includes Rave Lite, a simplified version designed for Phase I, Phase IV, feasibility, and post-market studies that need a faster, more pre-configured setup than a full Rave implementation. Rave connects to the wider Medidata Platform, including eConsent, eCOA, RTSM, and imaging, so sponsors running a multinational program can aggregate data from those modules without manual reconciliation. Medidata reports that protocol amendments and mid-study changes can be deployed without downtime. The platform is used by pharmaceutical, biotech, and MedTech companies as well as CROs and academic institutions, and pricing is subscription-based with terms that scale to trial size and complexity.

3. Veeva Vault EDC

Veeva provides Veeva EDC as part of the broader Veeva Clinical Platform, which also includes CTMS, eTMF, RTSM, eCOA, and study startup on one connected system. Study builds use an in-product specification studio built on Agile design principles, and role-based interfaces are designed to speed source data verification and medical assessments. Veeva reports that customers see up to 50 percent faster build times and can implement study changes without the custom coding that older EDC systems often require. The platform handles complex trial designs, including multi-arm adaptive studies, and is used by biopharma companies and CROs, including several of the largest global sponsors that have standardized on the Veeva Clinical Platform.

4. Castor EDC

Castor EDC runs its EDC and eCOA modules on a single database, which the company positions as removing the integration overhead of connecting separate systems. The platform includes a low-code eCRF Builder, and Castor states that low-complexity studies can be deployed in as little as 3 to 4 weeks. Castor supports FDA 21 CFR Part 11, ICH GCP, GDPR, HIPAA, ISO 27001, and ISO 9001, and reports more than 99.9 percent platform uptime. The company serves biotech, MedTech, CRO, biopharma, and academic research customers, and also offers eConsent and an AI-assisted data extraction tool called Catalyst as add-on modules within the same platform.

5. Medrio

Medrio provides a no-code EDC and clinical data management system alongside eCOA/ePRO, eConsent, and randomization and trial supply management on a single platform. The company positions itself for small and scaling clinical teams that need enterprise-grade validation without the complexity or programming dependency of larger systems. Medrio reports its EDC has supported thousands of completed studies with sites across 30-plus countries, and states that sponsors and CROs can configure and adjust studies without a programmer. The platform serves MedTech, pharma and biotech, CRO, and animal health customers, and Medrio also offers dedicated clinical data services, including database build and biostatistical support, for teams that want to supplement in-house resources.

6. Oracle

Oracle offers Clinical One Data Collection as part of its broader Oracle Life Sciences suite. The service unifies data capture from case report forms, wearable sensors, patient apps, electronic health records, and labs into a single platform, built on Oracle Cloud Infrastructure. Clinical One also includes randomization and trial supply management, with AI-powered forecasting for supply and inventory workflows, and connects to Oracle's eTMF and CTMS applications for teams that want a single vendor across those functions. Oracle's customers include CROs such as Atorus Research, Excelya, and FHI Clinical, alongside MedTech sponsors running device trials. The platform is aimed primarily at large biopharma and enterprise-scale programs.

7. OpenClinica

OpenClinica is a modular eClinical platform combining EDC, eConsent, eCOA, randomization, and an EHR-to-EDC integration tool called Unite, alongside reporting and analytics. The company reports its platform has supported more than 15,000 studies across 100-plus countries and more than 3 million participants. OpenClinica's EDC includes an intuitive form builder along with automated workflows and notifications, and the company states it supports a wide range of trial types, including adaptive platform, observational, and registry studies. OpenClinica serves academic research organizations, CROs, and pharma, biotech, and MedTech sponsors, with pricing and support positioned toward teams that want lower total cost without sacrificing validation and compliance features.

What to look for in EDC solutions for clinical trials in Latin America

Regulatory flexibility across multiple health authorities

A Latin America program rarely answers to a single regulator. Brazil's ANVISA, Mexico's COFEPRIS, Argentina's ANMAT, and Colombia's INVIMA each expect their own documentation and submission conventions, and a platform that treats every country as a bespoke build multiplies your dependency on the vendor with every added site.

Best-in-class platforms let your own data management team reuse a core eCRF design and adapt country-specific variants without a full re-validation cycle for each one. That reuse is what keeps a five-country program from becoming five separate vendor relationships.

Overlook this and a single protocol amendment turns into a queue of tickets, one per country, each waiting on a different vendor timeline.

Language coverage that reaches the site, not just the head office

Most Latin America programs run primarily in Spanish and Portuguese at the site level, even when the sponsor's internal team works in English. The platform needs to put forms and participant-facing diaries in front of site staff and patients in their working language, not just offer a translated marketing page.

Best-in-class support means native-language forms with default-language logic set per site, so a coordinator in Bogotá and one in São Paulo each see their own language without extra configuration. For patient-reported outcomes specifically, this extends to mobile ePRO diaries that patients complete on their own devices.

Amendment turnaround under variable connectivity

Sites outside major metro areas in Latin America often run on inconsistent broadband, and a platform's assumptions about connectivity matter more here than in a program concentrated in a handful of large hospitals. A browser-based EDC that performs well on lower bandwidth, paired with a mobile-first ePRO option, keeps data flowing even when a site's connection is unreliable.

A platform built assuming constant high-speed access risks missed diary entries and slower query resolution exactly where you can least afford it, at sites already managing infrastructure constraints.

Support coverage across a wide time zone spread

Latin America spans roughly GMT-3 to GMT-7, which means a support desk staffed for a single region can leave sites waiting hours for a response to an urgent build issue. Confirm 24/7 coverage with direct escalation paths, not a ticket queue, before you commit.

How to choose the right EDC solution for clinical trials in Latin America

Step 1: Map your country footprint and regulatory touchpoints

List every country your program touches and the specific health authority requirements each one carries. A platform that fits a single-country Brazil study may not hold up once Mexico and Colombia sites join the same protocol.

Step 2: Assess who owns in-country configuration

Decide whether your own site and data management teams need to configure Spanish and Portuguese forms directly, or whether every change routes through a central vendor team. The answer changes how much delay a mid-study amendment introduces.

Step 3: Evaluate connectivity assumptions built into the protocol

If your sites recruit outside major urban centers, check the platform's minimum bandwidth requirements and whether ePRO works reliably on mobile devices with intermittent connectivity.

Step 4: Scrutinize the support model against your time zone spread

Confirm the vendor offers genuine 24/7 support with direct escalation, not ticket-only response, especially if your program runs across several Latin American time zones simultaneously.

Step 5: Choose a platform built for multi-country self-sufficiency

A platform sized for this kind of program lets your team own configuration in-house rather than routing every country-specific change through a vendor queue. Viedoc's EDC software is built around that self-service model, with 40-plus languages and transparent, study-based pricing that doesn't penalize you for adding sites. Book a demo to see how a multi-country build works in practice.

Frequently asked questions

What is the best EDC platform for clinical trials in Latin America?

Viedoc's EDC software is the strongest fit for CROs and sponsors running multi-country Latin America programs, with 40-plus language support, study builds typically completed in 8 to 12 weeks, and a no-code Designer that keeps configuration in-house rather than routing through a vendor for every country-specific change. Castor EDC is a reasonable alternative for smaller, single-country studies that value its low-code eCRF builder. Medrio also fits lean teams running early-phase or MedTech studies that don't need the full breadth of a multi-module eClinical suite.

What should I look for when choosing an EDC platform for a multi-country Latin America program?

Prioritize regulatory flexibility across the specific health authorities your countries answer to, native Spanish and Portuguese support at the site level, and a configuration model that doesn't force every amendment through a central vendor team. Connectivity resilience and support coverage across a wide time zone spread matter just as much as core EDC features once a program spans several countries.

How long does it take to build and deploy a clinical study on a modern EDC platform?

Timelines vary by platform and study complexity, but modern EDC systems typically complete a study build in a matter of weeks rather than months. Self-service platforms with no-code configuration tend to move faster because the sponsor's own team can build and adjust forms directly, rather than waiting on a vendor's programming queue.

Does Viedoc support Spanish and Portuguese for site and participant-facing forms?

Yes. Viedoc's platform is available in 40-plus languages, including Spanish and Portuguese, with a default language set per site during study design. This extends to Viedoc's ePRO module, so participants complete diaries and questionnaires on their own devices in their own language, which supports better compliance in remote or underserved areas.

What compliance certifications matter for trials running across multiple Latin American countries?

Look for ISO 27001 and SOC 2 certification as a baseline for data security, alongside FDA 21 CFR Part 11 compliance if any data will support a US submission, and GDPR-aligned practices if the sponsor is EU-based. ICH GCP compliance is the common thread across all major regulators in the region, and structured audit-readiness documentation, such as Viedoc's Inspection Readiness Packet, helps demonstrate that posture during a health authority inspection.

How does Viedoc's study build time compare to Medidata's?

Viedoc's study builds are typically completed in 8 to 12 weeks, averaging 10, using a no-code Designer that lets a sponsor's own data management team configure and adjust studies directly. Medidata's Rave EDC build timelines can extend toward 90 days for a full implementation, though its Rave Lite option is designed to move faster for early-phase and simpler studies.

Making the right EDC choice for clinical trials in Latin America

The platforms reviewed here share a compliant, browser-based foundation for capturing trial data, but they diverge sharply on how much configuration work a sponsor or CRO can own directly versus how much routes back through the vendor. The global eClinical software market is estimated at more than $11 billion in 2025 and is projected to grow at roughly 14 percent annually, with expansion increasingly reaching regions like Latin America that were previously underserved by dedicated eClinical infrastructure.

Matching a platform to your program means weighing your country footprint, in-house configuration capacity, site-level connectivity, and budget model together, not in isolation. A program concentrated in a couple of large urban hospitals has different needs than one spanning rural sites across several countries, and a lean data management team weighs vendor dependency differently than a team with dedicated IT support.

Switching platforms mid-portfolio carries a validation cost that compounds with every protocol amendment routed through unfamiliar configuration logic, which makes the platform chosen for a first Latin America study a decision that shapes every study that follows in the region.

Why Viedoc is the best EDC choice for clinical trials in Latin America

If your program spans multiple Latin American countries, the platform you choose either scales with that complexity or multiplies it. Viedoc's EDC software has run more than 8,000 studies across 75-plus countries, with builds typically completed in 8 to 12 weeks using a no-code Designer that keeps configuration in your team's hands rather than a vendor's queue.

Operationally, that means unlimited user seats at no extra cost, transparent study-based pricing that doesn't penalize you for adding sites in a new country, and 24/7 support across global offices, so a build issue in São Paulo doesn't wait on a different time zone's business hours. Viedoc's tiered CRO program also gives partner CROs a structured path to prioritized support at the portfolio level.

On compliance, Viedoc is ISO 27001 and SOC 2 certified, supports 21 CFR Part 11, GDPR, HIPAA, and ICH GCP, and provides the Viedoc Inspection Readiness Packet to every customer as standard. Founded in 2003, Viedoc has more than two decades of clinical trial deployment behind it.

If you're weighing platforms for a multi-country Latin America program, book a demo or request a proposal and we'll walk through build speed, language coverage, and compliance in the context of your own country footprint.